MyAverix Finance
US · Healthcare
Ensysce Biosciences Inc (ENSC)
Biotechnology
Ensysce Biosciences Inc (ENSC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $4.68M, P/E ratio is 25.00, net margin is -250.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ENSC
Ensysce Biosciences Inc (ENSC) — FAQ
What is Ensysce Biosciences Inc's market cap?
Ensysce Biosciences Inc (ENSC) has a reported market cap of $4.68M (data as of 2026-05-24).
What is ENSC's P/E ratio?
The price-to-earnings (P/E) ratio for Ensysce Biosciences Inc (ENSC) is 25.00 (data as of 2026-05-24).
Does Ensysce Biosciences Inc pay a dividend?
Dividend yield is not available in the current snapshot for Ensysce Biosciences Inc (ENSC). Check the MyAverix Finance app for the latest dividend data.
What sector is Ensysce Biosciences Inc in?
Ensysce Biosciences Inc (ENSC) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ENSC listed on?
ENSC is listed on US.
What is Ensysce Biosciences Inc's net margin?
Ensysce Biosciences Inc (ENSC) reports a net margin of -250.4% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.